South Korea's HK inno.N Targets Cell Therapy, Vaccine Expansion Following $500m IPO

Record High Subscriptions From Institutional Investors

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.